about
Transcranial magnetic stimulation for the treatment of epilepsyTranscranial magnetic stimulation for the treatment of epilepsyClonazepam add-on therapy for refractory epilepsy in adults and childrenUpdate on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsyComputational analysis in epilepsy neuroimaging: A survey of features and methodsTowards precision medicine in epilepsy surgeryPerampanel for focal epilepsy: insights from early clinical experiencePharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive ToolsMagnetoencephalography in pediatric epilepsyUncovering the neurobehavioural comorbidities of epilepsy over the lifespanNeuroimaging the epileptogenic processPerampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizuresFunctional Connectome before and following Temporal Lobectomy in Mesial Temporal Lobe EpilepsyCannabinoids and Epilepsy.Seizure-induced oxidative stress in temporal lobe epilepsyManaging drug-resistant epilepsy: challenges and solutionsPost-Traumatic, Drug-Resistant Epilepsy and Review of Seizure Control Outcomes from Blinded, Randomized Controlled Trials of Brain Stimulation Treatments for Drug-Resistant EpilepsyStereotactic Laser Ablation for Medically Intractable Epilepsy: The Next Generation of Minimally Invasive Epilepsy SurgeryVitamin D3 for the Treatment of Epilepsy: Basic Mechanisms, Animal Models, and Clinical TrialsMapping the spatio-temporal pattern of the mammalian target of rapamycin (mTOR) activation in temporal lobe epilepsyGenetic association analysis of ATP binding cassette protein family reveals a novel association of ABCB1 genetic variants with epilepsy risk, but not with drug-resistanceZ944, a Novel Selective T-Type Calcium Channel Antagonist Delays the Progression of Seizures in the Amygdala Kindling ModelA genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsyReview of Commercially Available Epilepsy Genetic Panels.[Brivaracetam for add-on treatment in focal epilepsy].Astrocyte control of synaptic NMDA receptors contributes to the progressive development of temporal lobe epilepsy.Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy.Evaluation of magnetic resonance imaging-negative drug-resistant epilepsyThe preoperative evaluation and surgical treatment of epilepsy.Single-cell recordings in the human medial temporal lobe.Pharmacoresistance and the role of surgery in difficult to treat epilepsy.Syncope and Epilepsy coexist in 'possible' and 'drug-resistant' epilepsy (Overlap between Epilepsy and Syncope Study - OESYS)Ketogenic diet in the treatment of epilepsy in children under the age of 2 years: study protocol for a randomised controlled trialPhotolysis of Caged-GABA Rapidly Terminates Seizures In Vivo: Concentration and Light Intensity DependenceChemical-genetic attenuation of focal neocortical seizures.Synaptic roles of cyclin-dependent kinase 5 & its implications in epilepsyHippocampal neuropathology of domoic acid-induced epilepsy in California sea lions (Zalophus californianus).Deep brain stimulation for the treatment of epilepsy: circuits, targets, and trials.The role of resting state networks in focal neocortical seizures.Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy.
P2860
Q24197710-49021FA5-DE72-400F-BCBF-4DC9D33CC9D5Q26470461-A01BEB55-86A7-4933-A61E-CAFA9EBDB394Q26471687-B416EDE0-3A47-4BDC-B099-26758906A94DQ26745780-3C277A21-B167-4CDE-8115-7E45F4AC8815Q26750063-BE6A0703-3007-419D-9562-F3BEA40A5531Q26764961-0C4AFF24-3C84-4DF6-9E33-49BA8BF9DE3CQ26778392-3E996E97-3041-4108-97E4-EFAAF1761583Q26795786-AAB1E9BF-338A-4A80-AFCE-D1063669F304Q26825280-D43C7828-A15D-4BE4-9584-89F5BEC77B2BQ26865786-1ADD370C-9CDB-495A-8B47-B22084E38472Q26992310-622155E0-392A-48B3-8514-3515FE87A52EQ27007851-220A8AAA-357D-46B1-BCF3-5993DC3E7065Q27331968-EA8F8DEA-C089-476C-B08E-C37054A57A5CQ27336451-1BA780A7-4221-4287-B743-C176241A70A8Q27692712-96CC5DE6-35F4-42AC-9551-696E58DBAEA9Q28066264-97A8D65A-2754-4D7A-9F25-195614801F68Q28067183-C1E7CC5C-3687-4BA7-923E-C5A2764AF100Q28068022-39C8FD28-A57B-4EC3-A607-521BFD5187EDQ28069486-C7BEBF3E-73C4-483D-AF05-51EF2EB8E0B0Q28480776-1C5998C2-A224-4A36-B632-87302FE96395Q28540047-F5A7D943-0117-4AC7-8020-3092E5BAA192Q28547293-CB55755C-6744-44D7-876F-0420BF06D211Q28943418-938973F6-08A4-4A8B-8770-DA23FC25AF28Q30278398-B8BB18C9-47CF-4583-B285-72FCE67432FDQ30390285-5C5C454D-2540-432C-8661-F9661F0AF190Q30554433-83642587-D3A6-4811-901F-7425E7781965Q30577655-C7338A23-BB32-4FCC-B6B9-B9CC871AB043Q30813369-361D314B-4081-4F7E-AF1F-1CF0EA4A9E75Q30826781-DF90687A-68D2-4AB9-A083-1FD2AEFB04F2Q30845412-BA609629-851D-480E-B3A8-99DD17B18EBDQ33161739-97CC443A-6FC7-4A90-92CC-1CB9DF7EF23EQ33168318-1E162215-8728-4440-9696-5C9A7704C0CCQ33608771-9283F612-91F1-4701-9D06-53DE9A649D14Q33700856-3662D516-9FC7-4318-B063-C839910E7BAEQ33729364-53C751A8-65EE-453B-BFD6-9ECD847FB420Q33882756-C3EDAAAB-3C25-400B-9F6B-1314AAAF4156Q33909109-347399B1-794D-429A-8768-35C55950DB29Q34000803-EDC114A4-1774-477E-93DA-37AFACCE2C23Q34231733-A8F3220C-D377-43B9-BDDF-0E26DCB79B9AQ34311339-AC9577AA-24E1-4291-9B45-BB7F350441B3
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug-resistant epilepsy.
@en
Drug-resistant epilepsy.
@nl
type
label
Drug-resistant epilepsy.
@en
Drug-resistant epilepsy.
@nl
prefLabel
Drug-resistant epilepsy.
@en
Drug-resistant epilepsy.
@nl
P2093
P921
P356
P1476
Drug-resistant epilepsy.
@en
P2093
Martin J Brodie
Patrick Kwan
Steven C Schachter
P304
P356
10.1056/NEJMRA1004418
P407
P577
2011-09-01T00:00:00Z